Research programme: alopecia therapeutic - Safety Shot
Latest Information Update: 27 Feb 2024
At a glance
- Originator Applied Biology
- Developer Safety Shot
- Class Skin disorder therapies
- Mechanism of Action G protein-coupled receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alopecia